• Chemerin, cNTS Signaling, and Blood Pressure

  2026-09-04

  This 2024 study identifies a chemerin–CMKLR1–NADPH oxidase–superoxide pathway in the caudal nucleus tractus solitarius that increases sympathetic activity, arterial pressure, and heart rate. Its pharmacological dissection further suggests that downstream transmission through the paraventricular nucleus depends on NMDA, rather than AMPA/kainate, receptor signaling.

• iTBS Improves Motor Coordination in SCA3 Mice

  2026-09-03

  A 2026 study found that intermittent theta-burst stimulation improved motor coordination and gait while reducing cerebellar ataxin-3 pathology in SCA3/MJD mice. The results associate iTBS with a more anti-inflammatory microglial profile and enhanced autophagy, and indicate greater efficacy than continuous theta-burst stimulation in this model.

• Etoposide (VP-16) and Senescence Assays

  2026-09-03

  Etoposide (VP-16) is more than a DNA damage reagent: it can help researchers resolve the boundary between apoptosis, recovery, and senescence-like arrest. This guide integrates topoisomerase II biology with the 2025 LAMP1 senescence findings to improve assay design and interpretation.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-09-02

  The reference study shows that dietary Arachidonic Acid can accelerate rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of lymph-node arachidonate metabolism, particularly PGI2-cAMP-PKA signaling, as a regulator of CD86 expression and B-cell AID activity.

• Heparin Sodium for HSPG Uptake and Coagulation

  2026-09-02

  Heparin sodium supports two complementary research workflows: quantitative coagulation benchmarking and mechanistic testing of heparan sulfate proteoglycan-dependent nanovesicle uptake. This guide combines anti-factor Xa activity assay design, activated partial thromboplastin time (aPTT) measurement, practical competition experiments, and troubleshooting for translational cell and thrombosis research.

• Prostate Progenitors in Epithelial Homeostasis

  2026-09-01

  Sophie Viala’s 2024 McGill thesis examines how Gata3 and BMP5 regulate prostate basal stem/progenitor cells and combines organoid, allograft, live-imaging, and single-cell approaches to study epithelial development. Its findings connect progenitor pool size and regenerative capacity with molecular regulation while showing that oriented cell division and cell-fate specification can become temporally uncoupled.

• HyperFluor 488 Goat Anti-Mouse IgG for PRRSV Assays

  2026-09-01

  Use HyperFluor 488 Goat Anti-Mouse IgG to connect mouse-primary immunostaining with PRRSV-1 isolation, cell tropism, and tissue-pathology workflows. Its H+L reactivity supports sensitive immunofluorescence, flow cytometry, western blotting, and immunohistochemistry while practical optimization steps help control background and photobleaching.

• Baicalin Workflows for Plasticity and Cancer

  2026-08-31

  Baicalin supports a defined, mechanism-oriented workflow spanning adult visual-cortex plasticity and preclinical cancer research. This guide translates the reference study into dose controls, imaging choices, pathway assays, formulation safeguards, and troubleshooting decisions.

• Risedronate Sodium: Applied Research Workflows

  2026-08-31

  Build reproducible bone-resorption, uptake, and delivery studies with Risedronate Sodium, a mechanistically defined FPP synthase inhibitor. The workflow also shows how nanotransfersomes, dissolving microneedles, and inhaled systems can address exposure limitations that conventional oral dosing may leave unresolved.

• Protease Inhibitor Cocktail for MRSA Protein Workflows

  2026-08-30

  Protect fragile protein signals during MRSA nanomedicine studies, from cell disruption to phosphorylation analysis and immunoprecipitation. This EDTA-free, 100X DMSO formulation combines broad protease coverage with compatibility for assays that depend on divalent cations.

• Caffeic Acid Phenethyl Ester in NF-κB Research

  2026-08-29

  Caffeic Acid Phenethyl Ester (CAPE) provides a practical chemical perturbation for separating NF-κB-dependent inflammation from Stat3-linked neurodegeneration. This workflow connects zebrafish live imaging and cytokine assays with CAPE anti-angiogenesis research, while emphasizing controls for solubility, timing, toxicity, and pathway specificity.

• (-)-JQ1: BET Inactive Control Workflows

  2026-08-28

  Use (-)-JQ1, the inactive JQ1 stereoisomer, to separate BET-dependent biology from solvent, handling, and compound-exposure artifacts. A matched workflow is especially valuable for HPV-associated HNSCC experiments measuring viral transcription, BRD4-linked cellular genes, cell-cycle arrest, and apoptosis.

• Macrophage EP4 Loss Accelerates Atherosclerosis

  2026-08-28

  Tang and colleagues identify macrophage EP4 as a protective regulator of atherosclerosis and connect its loss to increased CD36 expression, foam-cell formation, and M1 polarization. By combining a myeloid-specific knockout model with oxLDL-stimulated cells and transcriptomic, proteomic, qPCR, and immunoblot analyses, the study provides a mechanistic framework for understanding how prostaglandin signaling influences inflammatory lipid handling.

• Vemurafenib (PLX4032, RG7204) in Cell Assays

  2026-08-27

  A scenario-driven guide to using Vemurafenib (PLX4032, RG7204), SKU A3004, in melanoma viability, proliferation, and resistance experiments. It connects BRAF V600E biology with practical handling, genotype controls, resistance interpretation, and evidence-based product selection.

• α-Linolenic Acid Research Workflows

  2026-08-27

  Build reproducible ALA experiments around lipid handling, dose-response design, and oxidation control. This guide connects α-Linolenic Acid workflows with cardiovascular, inflammation, cancer, and immune assays while clearly separating established evidence from testable research extensions.

8455 records 1/564 page Next 12345 下5页 Last page